Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  INC Research Holdings Inc    

INC RESEARCH HOLDINGS INC
My previous session
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Pomerantz Law Firm Investigates Claims On Behalf of Investors of INC Research Holdings, Inc. - INCR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 05:37pm CEST

NEW YORK, Nov. 10, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of INC Research Holdings, Inc. ("INC Research" or the "Company") (NASDAQ: INCR). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether INC Research and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On August 1, 2017, INC Research and inVentiv Health, Inc. ("inVentiv Health") announced the completion of a merger between the two companies. On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company's combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses.

On this news, INC Research's share price fell $16.35, or 28.43%, to close at $41.15 on November 9, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-inc-research-holdings-inc--incr-300553910.html

SOURCE Pomerantz LLP


© PRNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INC RESEARCH HOLDINGS INC
08/24SYNEOS HEALTH : Greg Rush joins Parexel as Executive VP & CFO
AQ
08/21SYNEOS HEALTH : Acquires Kinapse to Further Enhance End-to-End Capabilities
AQ
08/21SYNEOS HEALTH : acquires consulting firm to boost regulatory, safety, pharmacovi..
AQ
08/21SYNEOS HEALTH : acquires advisory & operational solutions provider Kinapse
AQ
08/20SYNEOS HEALTH, INC. : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
08/20Syneos Health™ Acquires Kinapse to Further Enhance End-to-End Capabilit..
GL
08/17Syneos Health to Present at the 2018 Baird Global Healthcare Conference
GL
08/17SYNEOS HEALTH : PAREXEL Announces Appointment of Two Key Executives
AQ
08/08SYNEOS HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Stat..
AQ
08/08SYNEOS HEALTH : Announces Pricing of Secondary Offering of Common Stock
AQ
More news
News from SeekingAlpha
01/03INC Research CFO exiting post at April's end 
2017INC Research Holdings 2017 Q3 - Results - Earnings Call Slides 
2017INC Research's (INCR) CEO Alistair MacDonald on Q3 2017 Results - Earnings Ca.. 
2017Midday Gainers / Losers 
2017INC Research misses by $0.08, misses on revenue